506879 — Gujarat Themis Biosyn Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹44.05bn
- IN₹45.61bn
- IN₹1.66bn
Annual cashflow statement for Gujarat Themis Biosyn, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 590 | 775 | 793 | 655 | 621 |
| Depreciation | |||||
| Non-Cash Items | -20.8 | -50.1 | -36 | -5.58 | 23 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -189 | -355 | -156 | 204 | -285 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 403 | 395 | 642 | 910 | 488 |
| Capital Expenditures | -139 | -237 | -746 | -1,162 | -1,725 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -159 | 32.9 | 194 | 43.3 | 2.58 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -298 | -204 | -552 | -1,118 | -1,723 |
| Financing Cash Flow Items | -2.05 | -1.11 | -0.894 | -4.28 | -64.1 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -140 | -133 | -85.9 | 260 | 1,149 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -35.1 | 57.9 | 4.14 | 52.2 | -85.7 |